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Gut-grabbing T cells trigger GVHD
 
Effector CD8
 
 
 
 T cells that cling to the intestine trigger graft-versus-host disease 
(GVHD), according to El-Asady and colleagues on page 1647. By contrast, 
effector T cells that pass through the intestine but do not linger—due to a lack of 
the integrin CD103—fail to induce disease.
GVHD is a serious complication of bone marrow transplantation in which 
donor-derived T cells infiltrate and attack host epithelial tissues such as skin and 
intestine. Intestinal injury results from attack on host epithelial cells by donor CD8
 
 
 
 
effector T cells. Previous studies by this group showed that CD8
 
 
 
 T cell–mediated 
rejection of pancreatic islet allografts required T cell expression of the integrin 
CD103 whose ligand, E-selectin, is preferentially expressed on epithelial cells.
El-Asady and colleagues now show that tissue destruction in GVHD 
similarly requires CD103 expression on CD8
 
 
 
 T cells. Activated CD8
 
 
 
 T cells that 
accumulated in the intestine of host mice after allogeneic bone marrow 
transplant expressed CD103. Activated CD8
 
 
 
 T cells that migrated to other 
organs such as the liver or spleen, by contrast, did not express this integrin.
T cells lacking CD103 could still migrate to the intestines, but failed to 
accumulate there and did not trigger GVHD, indicating that development of GVHD 
required CD103-mediated adherence of T cells to the intestinal epithelium. The 
cytokine TGF-
 
 
 
, likely produced locally in the intestine, was the driving force behind 
the expression of CD103, as T cells with a defective TGF-
 
 
 
 receptor were unable to 
up-regulate CD103 and accumulate in the intestine.
Whether the CD103-expressing T cells induce GVHD directly or indirectly is not 
yet clear. The authors suspect the latter and propose that CD103-mediated adhesion 
allows the T cell receptor (TCR) to interact with its ligand on the gut epithelium. TCR 
ligation, they suggest, then triggers the secretion of chemokines that draw other 
damaging cells, such as TNF-producing macrophages, into the gut.
CD8  T cell-induced intestinal pathology during GVHD (top) 
is absent in mice lacking the integrin CD103 (bottom).
 
  
 
 T cells take on CMV
 
Latent cytomegalovirus (CMV) infection
can reactivate in patients undergoing
immunosuppression after organ trans-
plant. But 
 
  
 
 T cells escape immu-
nosuppression and are free to take
control of the infection, suggest Halary
and colleagues on page 1567. These
CMV-reactive 
 
  
 
 T cells also recog-
nized intestinal epithelial tumor cell lines,
suggesting that CMV-infected cells and
tumor cells may share a common, as yet
undefined, 
 
  
 
 T cell antigen.
 
  
 
 T cells are a heterogeneous
population of T cells that express a re-
stricted T cell receptor repertoire and,
unlike conventional 
 
  
 
 T cells, can be
activated in a major histocompatibility
complex (MHC)-independent fashion
by self-antigens. Most subsets of 
 
  
 
 T
cells reside in epithelial tissues such as
the skin and intestine. Studies in mice
have suggested that these cells are re-
quired for the control of various viral
and bacterial infections, but precise
roles for 
 
  
 
 T cells in humans have
been difficult to establish.
In previous work, this group noted
that a subset of 
 
  
 
 T cells expanded in
kidney transplant patients, but only
in those with active CMV infections.
A CMV-specific    T cell clone (4-29)
produces TNF in response to tumor epi-
thelial cell lines, but not normal epithelial 
cell lines.
 
They now find that 
 
  
 
 T cell lines
derived from transplant patients are
indeed CMV-specific, as they could
kill CMV-infected cells but not cells
infected with other related viruses.
In an interesting twist, many of
the CMV-reactive 
 
  
 
 T cell lines also
recognized epithelial tumor cell lines.
Although the identity of the potentially
shared ligand remains under investi-
gation, the authors suspect a local
stress-induced self-antigen, as CMV
replication often occurs preferentially
in epithelial cells.
The authors suggest that 
 
  
 
 T cells
may be uniquely able to respond to
CMV. The virus-specific 
 
  
 
 T cells,
which are abundant during primary in-
fections in otherwise healthy individuals,
will be crippled by posttransplant im-
munosuppression. But 
 
  
 
 T cells are
not immunosuppressed, and can still
attack CMV-infected cells.
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